Growth suppression of human oral cancer cells by candidate agents for cetuximab-side effects

Cetuximab, an inhibitor of the epidermal growth factor receptor that is used widely to treat human cancers including oral squamous cell carcinoma (OSCC), has characteristic side effects of skin rash and hypomagnesemia. However, the mechanisms of and therapeutic agents for skin rashes and hypomagnese...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental cell research 2019-03, Vol.376 (2), p.210-220
Hauptverfasser: Uzawa, Katsuhiro, Kasamatsu, Atsushi, Saito, Tomoaki, Kita, Akihiro, Sawai, Yuki, Toeda, Yuriko, Koike, Kazuyuki, Nakashima, Dai, Endo, Yosuke, Shiiba, Masashi, Takiguchi, Yuichi, Tanzawa, Hideki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!